Cantor Equity Partners V CEPV Hovers Near Trust Value Amid Minimal Movement Collegium Pharmaceutical Gains Attention on ADHD Portfolio Strength After Q1 Beat GROV Q1 2026 Earnings EPS Surprises to the Upside but Stock Drops on Disclosed Weakness Corporate Bet on Prediction Markets Intensifies Despite Regulatory Uncertainty